| The generation and application of patient-derived xenograft model for cancer research J Jung, HS Seol, S Chang Cancer research and treatment: official journal of Korean Cancer Association …, 2018 | 299 | 2018 |
| Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155 S Chang, RH Wang, K Akagi, KA Kim, BK Martin, L Cavallone, ... Nature medicine 17 (10), 1275-1282, 2011 | 271 | 2011 |
| microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer S Kim, E Lee, J Jung, JW Lee, HJ Kim, J Kim, H Yoo, HJ Lee, SY Chae, ... Oncogene 37 (22), 2982-2991, 2018 | 113 | 2018 |
| Three dimensional mixed-cell spheroids mimic stroma-mediated chemoresistance and invasive migration in hepatocellular carcinoma IA Khawar, JK Park, ES Jung, MA Lee, S Chang, HJ Kuh Neoplasia 20 (8), 800-812, 2018 | 101 | 2018 |
| Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations S Chang, K Biswas, BK Martin, S Stauffer, SK Sharan The Journal of clinical investigation 119 (10), 3160-3171, 2009 | 91 | 2009 |
| Development of novel therapeutic agents by inhibition of oncogenic microRNAs DD Nguyen, S Chang International journal of molecular sciences 19 (1), 65, 2017 | 86 | 2017 |
| BRCA1 and microRNAs: emerging networks and potential therapeutic targets S Chang, SK Sharan Molecules and cells 34, 425-432, 2012 | 64 | 2012 |
| Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature J Jung, CH Lee, HS Seol, YS Choi, E Kim, EJ Lee, JK Rhee, SR Singh, ... Oncotarget 7 (38), 62533, 2016 | 59 | 2016 |
| Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1 HS Seol, SE Lee, JS Song, JK Rhee, SR Singh, S Chang, SJ Jang Cancer letters 372 (1), 24-35, 2016 | 59 | 2016 |
| The role of miRNAs in immune cell development, immune cell activation, and tumor immunity: with a focus on macrophages and natural killer cells SJ Xu, HT Hu, HL Li, S Chang Cells 8 (10), 1140, 2019 | 58 | 2019 |
| Exosome as a delivery vehicle for cancer therapy B Moon, S Chang Cells 11 (3), 316, 2022 | 57 | 2022 |
| Development and characterization of a colon PDX model that reproduces drug responsiveness and the mutation profiles of its original tumor HS Seol, HJ Kang, SI Lee, NE Kim, T Im Kim, SM Chun, TW Kim, C sik Yu, ... Cancer letters 345 (1), 56-64, 2014 | 56 | 2014 |
| Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge J Jung, C Yeom, YS Choi, S Kim, EJ Lee, MJ Park, SW Kang, SB Kim, ... Oncotarget 6 (24), 20370, 2015 | 54 | 2015 |
| tRNA-derived small RNAs: novel epigenetic regulators J Park, SH Ahn, MG Shin, HK Kim, S Chang Cancers 12 (10), 2773, 2020 | 48 | 2020 |
| Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer S Kim, J Rhee, HJ Yoo, HJ Lee, EJ Lee, JW Lee, JH Yu, BH Son, G Gong, ... Cancer letters 357 (2), 488-497, 2015 | 47 | 2015 |
| Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production HS Seol, SE Lee, JS Song, HY Lee, S Park, I Kim, SR Singh, S Chang, ... Cancer letters 382 (2), 157-165, 2016 | 40 | 2016 |
| PLGA nanoparticles codelivering siRNAs against programmed cell death protein-1 and its ligand gene for suppression of colon tumor growth SY Kwak, S Lee, HD Han, S Chang, K Kim, HJ Ahn Molecular Pharmaceutics 16 (12), 4940-4953, 2019 | 39 | 2019 |
| BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage K Biswas, S Philip, A Yadav, BK Martin, S Burkett, V Singh, A Babbar, ... Nature communications 9 (1), 537, 2018 | 38 | 2018 |
| Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C/EBP-β-mediated MDSC infiltration S Kim, JH Song, S Kim, P Qu, BK Martin, WS Sehareen, DC Haines, ... Oncotarget 7 (10), 11094, 2016 | 36 | 2016 |
| ADAR1 and microRNA; a hidden crosstalk in cancer CJ Cho, SJ Myung, S Chang International journal of molecular sciences 18 (4), 799, 2017 | 32 | 2017 |
